Snapshot from Aug 25, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Governments / Ireland — National Centre for Pharmacoeconomics
Entity

Ireland — National Centre for Pharmacoeconomics

Tracked across 1 events · 8 articles · First seen Aug 14, 2026 · Last active Aug 14, 2026

Sentiment
0
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 0
Domestic
Ireland funding dispute over Skyclarys drug
The Republic of Ireland — Health Service Executive (HSE) Drugs Group recommended against reimbursing the drug Skyclarys (omaveloxolone) for the treatment of Friedreich's Ataxia, a rare progressive neuromuscular condition affecting about 200 people in Republic…
Impact: Provided the assessment that found limited efficacy and high cost, informing the HSE recommendation.
Aug 14, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Ireland — National Centre for Pharmacoeconomics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.